Français
ItalianoBond Novartis AG 5.2% ( US66989HBB33 ) in USD
| Issuer | Novartis AG | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  Switzerland
|
||||
| ISIN code |
 US66989HBB33 ( in USD )
|
||||
| Interest rate | 5.2% per year ( payment 2 times a year) | ||||
| Maturity | 05/11/2045 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | / | ||||
| Total amount | / | ||||
| Cusip | 66989HBB3 | ||||
| Standard & Poor's ( S&P ) rating | AA- ( High grade - Investment-grade ) | ||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||
| Next Coupon | 05/11/2026 ( In 71 days ) | ||||
| Detailed description |
Novartis AG is a Swiss multinational pharmaceutical company that researches, develops, manufactures, and markets a broad range of innovative medicines and healthcare solutions globally. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBB33, pays a coupon of 5.2% per year. The coupons are paid 2 times per year and the Bond maturity is 05/11/2045 The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBB33, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBB33, was rated AA- ( High grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||